PROHANCE

This brand name is authorized in Austria, Brazil, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug PROHANCE contains one active pharmaceutical ingredient (API):

1 Gadoteridol UNII 0199MV609F - GADOTERIDOL

Gadoteridol is a non-ionic paramagnetic contrast medium for Magnetic Resonance Imaging. Gadoteridol is for diagnostic use only. Read about Gadoteridol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROHANCE Solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08CA04	Gadoteridol	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 540700201158419, 540700202154417, 540700203150415
Country: CA	Health Products and Food Branch	Identifier(s): 02229056
Country: EE	Ravimiamet	Identifier(s): 1778632, 1778643, 1778654, 1778665, 1778687, 1778698, 1778700
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60377, 64474
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 539411, 539429, 539437, 539445
Country: FR	Base de données publique des médicaments	Identifier(s): 61258225, 69155907
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 399427, 399429, 399431, 399433, 399435
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-668102412
Country: JP	医薬品医療機器総合機構	Identifier(s): 7290407A1031, 7290407A2038, 7290407A3034, 7290407A4030, 7290407G1034, 7290407G2030
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087973, 1087974, 1087975, 1087976, 1087977, 1087978, 1087979, 1087980, 1087981, 1087982, 1087983, 1087984, 1087985, 1091482, 1091483
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100097278
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66183001, W66183002, W66183003, W66183004, W66183005, W66183006, W66183007, W66183008, W66184001, W66184002, W66184003, W66184004, W66184005, W66184006, W66184007, W66184008, W66184009
Country: US	FDA, National Drug Code	Identifier(s): 0270-1111